Lupin launches generic equivalent of Bumex Injection in US Farhat Nasim20 Nov 2024 12:43 PM ISTMumbai: Global pharma major Lupin Limited (Lupin) announced on Tuesday the launch of Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose...
Lupin bags tentative USFDA nod for Raltegravir Tablets for HIV-1 infection Ruchika Sharma9 Nov 2024 11:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Natco Pharma names Imtiyaz Basade as Senior Vice President - RAD, Pharma Division, Kothur Unit Ruchika Sharma5 Nov 2024 11:24 AM ISTTelangana: Natco Pharma has announced that Imtiyaz Basade has been appointed as Senior Vice President - RAD, Pharma Division, Kothur Unit w.e.f....
Lupin to focus on development of inhalers with near-zero global warming potential propellants Ruchika Sharma3 Nov 2024 11:00 AM ISTMumbai: Global pharma major Lupin Limited has announced its focus on formulating respiratory inhalers by incorporating a propellant with...
Lupin Gets CDSCO Panel Nod to Study Antidiabetic FDC Dr. Divya Colin1 Nov 2024 6:00 PM ISTNew Delhi: The drug major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin names Claus Jepsen as President, Global Specialty MD Bureau21 Oct 2024 6:22 PM ISTClaus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases.
Lupin launches first generic of Pred Forte in US with 180-day exclusivity MD Bureau16 Oct 2024 1:39 PM ISTPred Forte had estimated annual sales of USD 198 million in the U.S. (IQVIA MAT August 2024)
Indian branded pharma Sector sees a decline in growth: Report Farhat Nasim9 Oct 2024 6:54 PM ISTCompanies such as Dr Reddys Laboratories (DRRD), Zydus Lifesciences (ZYDUSLIF), Lupin (LPC), and Mankind Pharma (MANKIND) expected to outperform on a...
Indian pharma sector set for mixed quarter: Report Ruchika Sharma9 Oct 2024 4:16 PM ISTNew Delhi: The Indian pharmaceutical industry is projected to experience a mixed quarter, with slower growth anticipated in the branded formulations,...
Lupin gets 5 USFDA observations for Pune biotech facility Ruchika Sharma7 Oct 2024 11:30 AM ISTMumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with five observations at...
Lupin arm buys nine brands of Medical Nutritional Institute in South Africa Ruchika Sharma5 Oct 2024 12:30 PM ISTThe acquired brands include AntaGolin, RyChol, NeuroVance, SkinVance, FlamLeve, Rheumalin, SleepVance, ImmunoVance, and OviVance.
Lupin, Scope Ophthalmics Ireland ink pact to market Optase range of products in Mexico Ruchika Sharma2 Oct 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has signed a distribution agreement with Scope Ophthalmics Ireland (SCOPE) for the...
